Search - tctmd.com

Displaying 441 - 460 of 719

Sort: Relevancy | Date

Presentation TCT 2017

TCT 91: Antithrombotic Therapy Post Transcatheter Aortic Valve Replacement in Patients With No Indication for Anticoagulation

Presenter: Kurt Huber, Jamil Abdalla Saad, Dimitrios Alexopoulos, Antonio L. Bartorelli, Bjorn Redfors, Carlos E. Uribe

October 31, 2017

Presentation TCT 2017

TCT 51: Impact of Anticoagulation Therapy on Valve Hemodynamics and Clinical Outcomes After Bioprosthetic Aortic Valve Replacement: A Pooled Analysis of the PARTNER2 Trials

Presenter: Peter C. Block, Lars Sondergaard, Tarun Chakravarty, MD

October 31, 2017

Presentation TCT 2017

TCT 90: HAS-BLED Score and Other Predictors of Bleeding in Catheter-Directed Thrombolysis for Pulmonary Embolism

Presenter: Kurt Huber, Jamil Abdalla Saad, Kara Denby, MD

October 31, 2017

Presentation TCT 2017

TCT 50: Impact of Anticoagulation Therapy on Valve Hemodynamic Deterioration Following Transcatheter Aortic Valve Replacement

Presenter: Peter C. Block, Lars Sondergaard, Maria Del Trigo, MD

October 31, 2017

Presentation TCT 2017

TCT 89: Tradeoff Between Myocardial Infarction and Bleeding in Relation to Bleeding Risk - Insights From PARIS Registry

Presenter: Kurt Huber, Jamil Abdalla Saad, Sabato Sorrentino, MD

October 31, 2017

News Daily News

Preventing Dementia May Be Another Reason to Take Oral Anticoagulants for A-fib

Todd Neale

October 25, 2017

News Daily News

DOACs Not Associated With Major Bleeding, Mortality: Observational Analysis

Michael O'Riordan

October 19, 2017

News Daily News

Complications Spiked, Then Fell, After Initial Introduction of Watchman LAA Closure Device

Todd Neale

October 12, 2017

News Daily News

NOAC Bleeding Risk Rises With Several Drug Combinations

Michael O'Riordan

October 06, 2017

News Daily News

No Anticoagulation Benefit, High Bleeding Risk Seen in Patients With Secondary A-fib

Michael O'Riordan

September 29, 2017

News Daily News

Stroke, Bleeding Risks High in A-fib Patients With Contraindications to Anticoagulation

Todd Neale

September 27, 2017

News Daily News

Three New Positive PFO Closure Studies May Turn the Tide in Cryptogenic Stroke

Yael L. Maxwell

September 18, 2017

News Daily News

Rivaroxaban, Warfarin Provide Similar Results Early After Mild Strokes Related to A-fib

Todd Neale

September 14, 2017

News Conference News ESC 2017

EMANATE: Another NOAC Shown to Be Safe, Effective in the Setting of Cardioversion for A-fib

Todd Neale

September 05, 2017

News Conference News ESC 2017

ESC Releases Revamped DAPT Guidance Focusing on Personalized Approach

Todd Neale

September 01, 2017

News Conference News ESC 2017

IMPACT-AF: Education, Feedback Boost Oral Anticoagulation Use for A-fib

Todd Neale

August 30, 2017

News Conference News ESC 2017

Dual Antithrombotic Approach in Patients With A-fib Undergoing PCI Boosted in RE-DUAL PCI

Todd Neale

August 27, 2017

News Conference News ESC 2017

European Societies Issue New Valvular Heart Disease Guidelines, With Important Shifts

Shelley Wood

August 27, 2017

News Daily News

In Case of Emergency: Don’t Rely on ‘Normal’ Range Assays With DOACs

Shelley Wood

August 10, 2017

News Daily News

Women With A-fib Less Likely to Get Oral Anticoagulants Regardless of Risk

Leah Lawrence

August 03, 2017

Advertisement

TCT 91: Antithrombotic Therapy Post Transcatheter Aortic Valve Replacement in Patients With No Indication for Anticoagulation

TCT 51: Impact of Anticoagulation Therapy on Valve Hemodynamics and Clinical Outcomes After Bioprosthetic Aortic Valve Replacement: A Pooled Analysis of the PARTNER2 Trials

TCT 90: HAS-BLED Score and Other Predictors of Bleeding in Catheter-Directed Thrombolysis for Pulmonary Embolism

TCT 50: Impact of Anticoagulation Therapy on Valve Hemodynamic Deterioration Following Transcatheter Aortic Valve Replacement

TCT 89: Tradeoff Between Myocardial Infarction and Bleeding in Relation to Bleeding Risk - Insights From PARIS Registry

Preventing Dementia May Be Another Reason to Take Oral Anticoagulants for A-fib

DOACs Not Associated With Major Bleeding, Mortality: Observational Analysis

Complications Spiked, Then Fell, After Initial Introduction of Watchman LAA Closure Device

NOAC Bleeding Risk Rises With Several Drug Combinations

No Anticoagulation Benefit, High Bleeding Risk Seen in Patients With Secondary A-fib

Stroke, Bleeding Risks High in A-fib Patients With Contraindications to Anticoagulation

Three New Positive PFO Closure Studies May Turn the Tide in Cryptogenic Stroke

Rivaroxaban, Warfarin Provide Similar Results Early After Mild Strokes Related to A-fib

EMANATE: Another NOAC Shown to Be Safe, Effective in the Setting of Cardioversion for A-fib

ESC Releases Revamped DAPT Guidance Focusing on Personalized Approach

IMPACT-AF: Education, Feedback Boost Oral Anticoagulation Use for A-fib

Dual Antithrombotic Approach in Patients With A-fib Undergoing PCI Boosted in RE-DUAL PCI

European Societies Issue New Valvular Heart Disease Guidelines, With Important Shifts

In Case of Emergency: Don’t Rely on ‘Normal’ Range Assays With DOACs

Women With A-fib Less Likely to Get Oral Anticoagulants Regardless of Risk

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content